AbCellera Announces Expanded Research Collaboration with Teva VANCOUVER, British Columbia, June 13, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Teva Pharmaceutical Industries, Ltd....

AbCellera Announces an Antibody Discovery Program in Influenza Vaccine Research VANCOUVER, British Columbia, June 06, 2017 (GLOBE NEWSWIRE) -- AbCellera has entered into a collaborative research effort with Sanofi Pasteur, a global leader in the development and sale of vaccines...

AbCellera Announces Multi-Target Research Collaboration with Pfizer VANCOUVER, British Columbia, Jan. 05, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Pfizer Inc. (NYSE:PFE). AbCellera...

AbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic Candidates VANCOUVER, British Columbia, Aug. 24, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...